These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 24866341)
1. Design and synthesis of quinazolinone tagged acridones as cytotoxic agents and their effects on EGFR tyrosine kinase. Babu YR; Bhagavanraju M; Reddy GD; Peters GJ; Prasad VV Arch Pharm (Weinheim); 2014 Sep; 347(9):624-34. PubMed ID: 24866341 [TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and molecular docking studies of 2-(furan-2-yl)quinazolin-4-one derivatives as potential antiproliferative agents. Ahmed MF; Belal A Arch Pharm (Weinheim); 2015 Jul; 348(7):487-97. PubMed ID: 25921702 [TBL] [Abstract][Full Text] [Related]
3. Nitric oxide releasing acridone carboxamide derivatives as reverters of doxorubicin resistance in MCF7/Dx cancer cells. Rajendra Prasad VV; Deepak Reddy G; Kathmann I; Amareswararao M; Peters GJ Bioorg Chem; 2016 Feb; 64():51-8. PubMed ID: 26657603 [TBL] [Abstract][Full Text] [Related]
4. Studies for development of novel quinazolinones: new biomarker for EGFR. Aggarwal S; Sinha D; Tiwari AK; Pooja P; Kaul A; Singh G; Mishra AK Spectrochim Acta A Mol Biomol Spectrosc; 2015 May; 143():309-18. PubMed ID: 25766241 [TBL] [Abstract][Full Text] [Related]
5. Acridone-pyrimidine hybrids- design, synthesis, cytotoxicity studies in resistant and sensitive cancer cells and molecular docking studies. Murahari M; Prakash KV; Peters GJ; Mayur YC Eur J Med Chem; 2017 Oct; 139():961-981. PubMed ID: 28886509 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of N-phenylsulfonylnicotinamide derivatives as novel antitumor inhibitors. Zhang H; Lu X; Zhang LR; Liu JJ; Yang XH; Wang XM; Zhu HL Bioorg Med Chem; 2012 Feb; 20(4):1411-6. PubMed ID: 22277588 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of a novel series of 6,8-dibromo-4(3H)quinazolinone derivatives as anticancer agents. Ahmed MF; Youns M Arch Pharm (Weinheim); 2013 Aug; 346(8):610-7. PubMed ID: 23873839 [TBL] [Abstract][Full Text] [Related]
8. Molecular design, synthesis and biological research of novel pyridyl acridones as potent DNA-binding and apoptosis-inducing agents. Zhang B; Chen K; Wang N; Gao C; Sun Q; Li L; Chen Y; Tan C; Liu H; Jiang Y Eur J Med Chem; 2015 Mar; 93():214-26. PubMed ID: 25686590 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and in vitro antitumor activity of 4-aminoquinoline and 4-aminoquinazoline derivatives targeting EGFR tyrosine kinase. Abouzid K; Shouman S Bioorg Med Chem; 2008 Aug; 16(16):7543-51. PubMed ID: 18678492 [TBL] [Abstract][Full Text] [Related]
10. Discovery of new HER2/EGFR dual kinase inhibitors based on the anilinoquinazoline scaffold as potential anti-cancer agents. Sadek MM; Serrya RA; Kafafy AH; Ahmed M; Wang F; Abouzid KA J Enzyme Inhib Med Chem; 2014 Apr; 29(2):215-22. PubMed ID: 23402383 [TBL] [Abstract][Full Text] [Related]
11. Structure-based drug design and biological evaluation of 2-acetamidobenzothiazole derivative as EGFR kinase inhibitor. Gabr MT; El-Gohary NS; El-Bendary ER; El-Kerdawy MM J Enzyme Inhib Med Chem; 2015 Feb; 30(1):160-5. PubMed ID: 24601650 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, molecular docking and antitumor activity of novel pyrrolizines with potential as EGFR-TK inhibitors. Belal A Bioorg Chem; 2015 Apr; 59():124-9. PubMed ID: 25748126 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, biological evaluation, molecular docking and QSAR studies of 2,4-dimethylacridones as anticancer agents. Murahari M; Kharkar PS; Lonikar N; Mayur YC Eur J Med Chem; 2017 Apr; 130():154-170. PubMed ID: 28246041 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and antitumor activities of some new N1-(flavon-6-yl)amidrazone derivatives. Habashneh AY; El-Abadelah MM; Zihlif MA; Imraish A; Taha MO Arch Pharm (Weinheim); 2014 Jun; 347(6):415-22. PubMed ID: 24615985 [TBL] [Abstract][Full Text] [Related]
16. Targeting tyrosine kinase: Development of acridone - pyrrole - oxindole hybrids against human breast cancer. Kaur M; Singh P Bioorg Med Chem Lett; 2019 Jan; 29(1):32-35. PubMed ID: 30446310 [TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis and Antitumor Activities of Novel Quinazolinone Derivatives as Potential EGFR Inhibitors. Wang J; Huang L; Chen X; Yuan Y; Sun J; Yang M Chem Pharm Bull (Tokyo); 2022; 70(9):637-641. PubMed ID: 36047235 [TBL] [Abstract][Full Text] [Related]
18. Elucidation of chemosensitization effect of acridones in cancer cell lines: Combined pharmacophore modeling, 3D QSAR, and molecular dynamics studies. Gade DR; Makkapati A; Yarlagadda RB; Peters GJ; Sastry BS; Rajendra Prasad VVS Comput Biol Chem; 2018 Jun; 74():63-75. PubMed ID: 29547875 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and assessment of new series of quinazolinone derivatives as EGFR inhibitors along with their cytotoxic evaluation against MCF7 and A549 cancer cell lines. Aziz MW; Kamal AM; Mohamed KO; Elgendy AA Bioorg Med Chem Lett; 2021 Jun; 41():127987. PubMed ID: 33771586 [TBL] [Abstract][Full Text] [Related]
20. EGFR inhibition by pentacyclic triterpenes exhibit cell cycle and growth arrest in breast cancer cells. Sathya S; Sudhagar S; Sarathkumar B; Lakshmi BS Life Sci; 2014 Jan; 95(1):53-62. PubMed ID: 24333132 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]